AHIX yields 44444.44% · JNJ yields 2.13%● Live data
📍 AHIX pulled ahead of the other in Year 1
Combined, AHIX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AHIX + JNJ for your $10,000?
Aluf Holdings, Inc., through its subsidiaries, develops proprietary software, software algorithms, and hardware for testing and data mining of computer hard drives, memory, and magnetics, as well as semiconductor and nanotechnology- based device components. It builds advanced test solutions for engineering and manufacturing sectors to verify devices made correctly; reliability tests to predict when the device will fail during usage; and characterization tests to verify the manufacturing operation in building the device. Its product lines include Predictive, Demonstrated, and Quantitative (PDQ) - Wafer Level Reliability (WLR), a wafer level reliability test software package; the ASUR SDR software suite that provides an environment in which users can test semiconductor wafers by using the JEDEC compliant PDQ-WLR algorithm library; and ASUR PDR, which provides an immediate view of stresses and device behaviors through the use of its real-time plotting tool. The company also provides shipping and coordination services for retail and wholesale, electronics, and manufacturing companies worldwide; and operates cloud based tracking and e-logistics. In addition, it manufactures and processes CBD distillate, a THC-free, purified form of CBD. The company was formerly known as COREwafer Industries, Inc. and changed its name to Aluf Holdings, Inc. in August 2015. Aluf Holdings, Inc. was incorporated in 1977 and is headquartered in Hollywood, Florida.
Full AHIX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.